User profiles for Jessica J. Cunningham

Jessica J Cunningham

Fralin Biomedical Research Institute
Verified email at vtc.vt.edu
Cited by 1548

Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer

J Zhang, JJ Cunningham, JS Brown… - Nature …, 2017 - nature.com
Abiraterone treats metastatic castrate-resistant prostate cancer by inhibiting CYP17A, an
enzyme for testosterone auto-production. With standard dosing, evolution of resistance with …

Darwinian dynamics of intratumoral heterogeneity: not solely random mutations but also variable environmental selection forces

MC Lloyd, JJ Cunningham, MM Bui, RJ Gillies… - Cancer research, 2016 - AACR
Spatial heterogeneity in tumors is generally thought to result from branching clonal evolution
driven by random mutations that accumulate during tumor development. However, this …

Optimal control to develop therapeutic strategies for metastatic castrate resistant prostate cancer

JJ Cunningham, JS Brown, RA Gatenby… - Journal of theoretical …, 2018 - Elsevier
In metastatic castrate resistant prostate cancer (mCRPC), abiraterone is conventionally
administered continuously at maximal tolerated dose until treatment failure. The majority of …

Evolutionary dynamics in cancer therapy

JJ Cunningham, RA Gatenby… - Molecular …, 2011 - ACS Publications
Disseminated cancer remains a largely fatal disease. While systemic therapy can have some
initial success, it is rarely durable. Typically, populations of cancer cells resistant to therapy …

Spatial vs. non-spatial eco-evolutionary dynamics in a tumor growth model

…, JJ Cunningham, RA Gatenby, J Zhang… - Journal of theoretical …, 2017 - Elsevier
Metastatic prostate cancer is initially treated with androgen deprivation therapy (ADT).
However, resistance typically develops in about 1 year – a clinical condition termed metastatic …

Frequency-dependent interactions determine outcome of competition between two breast cancer cell lines

AR Freischel, M Damaghi, JJ Cunningham… - Scientific reports, 2021 - nature.com
Tumors are highly dynamic ecosystems in which diverse cancer cell subpopulations compete
for space and resources. These complex, often non-linear interactions govern continuous …

A call for integrated metastatic management

JJ Cunningham - Nature ecology & evolution, 2019 - nature.com
Jessica J. CunninghamCunningham, JJ A call for integrated metastatic management.
Nat Ecol Evol 3, 996–998 (2019). https://doi.org/10.1038/s41559-019-0927-x …

Coupled source-sink habitats produce spatial and temporal variation of cancer cell molecular properties as an alternative to branched clonal evolution and stem cell …

JJ Cunningham, A Bukkuri, JS Brown… - Frontiers in Ecology …, 2021 - frontiersin.org
Intratumoral molecular cancer cell heterogeneity is conventionally ascribed to the accumulation
of random mutations that occasionally generate fitter phenotypes. This model is built …

A phase 1b adaptive androgen deprivation therapy trial in metastatic castration sensitive prostate cancer

J Zhang, J Gallaher, JJ Cunningham, JW Choi… - Cancers, 2022 - mdpi.com
Simple Summary Despite early utilization of new hormonal agents (NHA, ie, abiraterone,
enzalutamide and apalutamide) for combined androgen deprivation therapy (ADT) for …

Aggregation effects and population-based dynamics as a source of therapy resistance in cancer

JS Brown, JJ Cunningham… - IEEE Transactions on …, 2016 - ieeexplore.ieee.org
Objective: Evolution of resistance allows cancer cells to adapt and continue proliferating even
when therapy is initially very effective. Most investigations of treatment resistance focus on …